MANDRAGORA-INJEEL FORTE LIQ (4D,8D,12D,30D,200D/1.1ML) DIN 02064707
Status: Cancelled Post Market
Holder: BIOLOGISCHE HEILMITTEL HEEL GMBH
Molecule: MANDRAGORA OFFICINARUM
Health Canada record
| Active ingredient(s) | MANDRAGORA OFFICINARUM 4 D |
|---|---|
| Dosage form | Liquid |
| Route | Oral |
| Schedule | HOMEOPATHIC |
| Class | Human |
| ATC | |
| Original market date | 31-Dec-1994 |
| Current status date | 18-Aug-1998 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing MANDRAGORA OFFICINARUM
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02234598 | MANDRAGORA OFFICINARUM | DOLISOS CANADA INC. | Granules; Liquid; Globules | MANDRAGORA OFFICINARUM 1 X | Cancelled Post Market |
| 02064715 | MANDRAGORA-INJEEL LIQ (8D,12D,30D,200D/1.1ML) | BIOLOGISCHE HEILMITTEL HEEL GMBH | Liquid | MANDRAGORA OFFICINARUM 8 D | Cancelled Post Market |